The effect of emicizumab regimen on haemophilia outcomes

Lancet Haematol. 2019 Jun;6(6):e286-e287. doi: 10.1016/S2352-3026(19)30070-5. Epub 2019 Apr 16.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Bispecific*
  • Antibodies, Monoclonal, Humanized
  • Hemophilia A*
  • Humans

Substances

  • Antibodies, Bispecific
  • Antibodies, Monoclonal, Humanized
  • emicizumab

Associated data

  • ClinicalTrials.gov/NCT02196207